MNKD
NASDAQ · Biotechnology
Mannkind Corp
$3.92
+0.16 (+4.26%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+706.4% upside
Low Target
$20.51
Average Target
$31.61
High Target
$34.61
Current Price
$3.92
Current
$3.92
$3.92
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Scenario Analysis
Bear Case
$20.51
423.2%
Low target
Base Case
$31.61
+706.4%
Avg target
Bull Case
$34.61
+782.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.51
-39.8% from high
52-Week Low
$2.23
+75.8% from low
Target vs 52W High
$31.61
+385.6% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.06
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |